The mRNA expression of ACTN4 evaluated by quantitative real-time PCR was a factor significantly associated with cancer-specific mortality in patients with stage I–II lung squamous cell carcinoma (HR, 2.68; 95%CI, 1.21–5.92) [86]. Here, ACTN4 is linked to cancer.